Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis
会议论文期刊论文
编号:
053bc3a8-e636-4b01-acf3-1082988eb561
作者:
Mok, Myth T.[1]Lee, YingYing[1,2]Kang, Wei[3]Yang, Weiqin[1]Tang, Wenshu[1]Wu, Feng[1]Xu, Liangliang[1]Yu, Zhuo[4]Lee, SauDan[5]Wong, Grace L. H.[2]Yip, Kevin Y. L.[5]To, KaFai[3,6]Cheng, Alfred S. L.[1,6]
语种:
英文
期刊:
CANCER SCIENCEISSN:1349-70062018 年109 卷(235 - 235) ; DEC
收录:
推荐引用方式 GB/T 7714:
Mok Myth T.,Lee Ying-Ying,Kang Wei, et al. Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis [J].CANCER SCIENCE,2018,109:235-235.
APA:
Mok Myth T.,Lee Ying-Ying,Kang Wei,Yang Weiqin,&Cheng Alfred S. L..(2018).Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis .CANCER SCIENCE,109:235-235.
MLA:
Mok Myth T., et al. "Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis" .CANCER SCIENCE 109(2018):235-235.
Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis
作者:
Mok, Myth T.[1]Lee, Ying-Ying[1,2]Kang, Wei[3]Yang, Weiqin[1]Tang, Wenshu[1]Wu, Feng[1]Xu, Liangliang[1]Yu, Zhuo[4]Lee, Sau-Dan[5]Wong, Grace L. H.[2]Yip, Kevin Y. L.[5]To, Ka-Fai[3,6]Cheng, Alfred S. L.[1,6]
来源出版物:
CANCER SCIENCE
2018 年109 卷(235 - 235)
增刊:
2
出版日期:
2018 DEC
ISSN/EISSN:
1349-7006
地址:
[1]CUHK, Sch Biomed Sci, Hong Kong, Peoples R China.
[2]CUHK, Dept Med & Therap, Hong Kong, Peoples R China.
[3]CUHK, Dept Anat & Cell Path, Hong Kong, Peoples R China.
[4]Shuguang Hosp, Dept Liver Dis, Shanghai, Peoples R China.
[5]CUHK, Dept Comp Sci & Engn, Hong Kong, Peoples R China.
[6]CUHK, State Key Lab Digest Dis, Hong Kong, Peoples R China.